Long-term follow-up of acalabrutinib in R/R mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 0:55 5 years ago 161 Скачать Далее
Acalabrutinib monotherapy in R/R MCL: extended follow-up results VJHemOnc – Video Journal of Hematology & HemOnc 3:42 3 years ago 168 Скачать Далее
Long-term ibrutinib outcomes vs. prior regimens: pooled analysis in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:35 4 years ago 219 Скачать Далее
One-Year Follow-up of ZUMA-2: KTE-X19 in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:11 3 years ago 96 Скачать Далее
ASCEND: 3 year follow-up of acalabrutinib in R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:30 2 years ago 147 Скачать Далее
42-Month Follow-Up Data of Acalabrutinib Monotherapy in R/R CLL Targeted Oncology 0:52 4 years ago 214 Скачать Далее
Selecting BTK inhibitors for patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 165 Скачать Далее
AstraZeneca's New CALQUENCE® Data in Mantle Cell Lymphoma (MCL) HPR 8:58 3 years ago 176 Скачать Далее
Andre Goy, MD, comments on the long-term outcome of acalabrutinib in MCL OBRoncology 0:51 5 years ago 108 Скачать Далее
Phase 2 Study of Acalabrutinib-Lenalidomide-Rituximab in Untreated Mantle Cell Lymphoma Patients WCMNYP JCTO 2:17 4 years ago 136 Скачать Далее
Acalabrutinib in combination with bendamustine & rituximab in treatment-naïve or R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:31 1 year ago 249 Скачать Далее
Long-Term Results of Ibrutinib/Umbralisib Show Efficacy in CLL and MCL Targeted Oncology 1:51 4 years ago 108 Скачать Далее
Dr. Jacobs on the Efficacy of Ibrutinib and Acalabrutinib in Patients With MCL OncLive 1:33 6 years ago 395 Скачать Далее
ASH 2017: Acalabrutinib Therapy for R/R Mantle Cell Lymphoma NE Live 4:41 6 years ago 66 Скачать Далее
